Centogene (CNTGF) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Centogene N.V., a notable entity in the biotech industry, has recently transitioned its former CFO, Jose Miguel Coego Rios, to a consultancy role. Rios’s new agreement with the company, effective from October 1, 2024, will have him offering business consulting services until the end of December 2024. This strategic move indicates Centogene’s commitment to leveraging experienced executive guidance to steer its future endeavors.
For further insights into CNTGF stock, check out TipRanks’ Stock Analysis page.